Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

28.00
Delayed Data
As of May 27
 +0.33 / +1.19%
Today’s Change
25.98
Today|||52-Week Range
43.85
-13.15%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close27.67
Today’s open27.67
Day’s range27.53 - 28.08
Volume349,178
Average volume (3 months)397,961
Market cap$1.4B
Dividend yield--
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-11.66%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-0.08%
P/E ratioNM
Price/Sales1.89
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.58+1.93%
PENPenumbra Inc+2.29+4.48%
ICUIICU Medical Inc+1.28+1.25%
OMCLOmnicell Inc+0.79+2.57%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.32
Annual revenue (last year)$909.7M
Annual profit (last year)-$55.6M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Christopher Simon
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers

Search for Jobs